| 1 |
32737944 | Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer. | 2021 Jan 8 |
1 |
| 2 |
33801507 | Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma. | 2021 Mar 2 |
1 |
| 3 |
31536751 | SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutations. | 2020 Jan |
1 |
| 4 |
31963392 | SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner. | 2020 Jan 17 |
1 |
| 5 |
28296148 | DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. | 2017 Jun |
1 |
| 6 |
26735173 | Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule. | 2016 Jan 26 |
2 |
| 7 |
27035541 | Differential effects of the two amino acid sensing systems, the GCN2 kinase and the mTOR complex 1, on primary human alloreactive CD4⁺ T-cells. | 2016 May |
1 |
| 8 |
25814188 | A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins. | 2015 May-Jun |
2 |